{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:30:35Z","timestamp":1789104635106,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejso.2026.111492","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:09:56Z","timestamp":1771891796000},"page":"111492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ten-year of French multicentric experience in the management of peritoneal mesothelioma with 924 patients"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-3836","authenticated-orcid":false,"given":"Barbara","family":"Noiret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Lenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Piessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Sgarbura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-8558","authenticated-orcid":false,"given":"Amelie","family":"Bruandet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111492_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","article-title":"A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma","volume":"18","author":"Yan","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib2","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib3","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","article-title":"Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial","volume":"26","author":"Simon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/14737140.2017.1340157","article-title":"First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma","volume":"17","author":"Fujimoto","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejso.2026.111492_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","article-title":"Malignant peritoneal mesothelioma-results from the international expanded access program using pemetrexed alone or in combination with a platinum agent","volume":"64","author":"Carteni","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejso.2026.111492_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"J\u00e4nne","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejso.2026.111492_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejso.2006.03.009","article-title":"Systemic chemotherapy in the management of malignant peritoneal mesothelioma","volume":"32","author":"Garcia-Carbonero","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejso.2020.02.011","article-title":"Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"47","author":"Kusamura","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib9","first-page":"6237","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.ejso.2026.111492_bib10","doi-asserted-by":"crossref","unstructured":"Noiret B, Clement G, Lenne X, et al. Centralization and oncologic training reduce postoperative morbidity and failure-to-rescue rates after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: study on a 10-year national French practice. Ann Surg. . Epub ahead of print August 21, 2020. DOI: 10.1097\/SLA.0000000000004326.","DOI":"10.1097\/SLA.0000000000004326"},{"key":"10.1016\/j.ejso.2026.111492_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","article-title":"The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"20","author":"Deraco","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12032-018-1125-4","article-title":"The impact of chemotherapy and its timing on survival in malignant peritoneal mesothelioma treated with complete debulking","volume":"35","author":"Naffouje","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","article-title":"Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE database: multi-institutional retrospective study","volume":"65","author":"Kepenekian","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2026.111492_bib14","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00423-022-02594-6","article-title":"Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"407","author":"Acs","year":"2022","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ejso.2026.111492_bib15","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Baratti","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2026.111492_bib16","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1245\/s10434-019-08138-5","article-title":"Predictors and outcomes of surgery in peritoneal mesothelioma: an analysis of 2000 patients from the national cancer database","volume":"27","author":"Bijelic","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib17","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1245\/s10434-014-3803-6","article-title":"Current trends in the management of malignant peritoneal mesothelioma","volume":"21","author":"Miura","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/SLA.0000000000001470","article-title":"Laparoscopic gastric mobilization reduces postoperative mortality after esophageal cancer surgery: a French nationwide study","volume":"262","author":"Messager","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111492_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/298369","article-title":"Estimation of national colorectal-cancer incidence using claims databases","volume":"2012","author":"Quantin","year":"2012","journal-title":"J Cancer Epidemiol"},{"key":"10.1016\/j.ejso.2026.111492_bib21","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/cncr.31269","article-title":"Adapting the elixhauser comorbidity index for cancer patients","volume":"124","author":"Mehta","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2026.111492_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111492_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2307\/2986296","article-title":"An exploratory technique for investigating large quantities of categorical data","volume":"29","author":"Kass","year":"1980","journal-title":"Applied Statistics"},{"key":"10.1016\/j.ejso.2026.111492_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/cancers15010229","article-title":"Contemporary trends in malignant peritoneal mesothelioma: incidence and survival in the United States","volume":"15","author":"Calthorpe","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111492_bib25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/cancers14040942","article-title":"Incidence, survival analysis and future perspective of Primary Peritoneal Mesothelioma (PPM): a population-based Study from SEER database","volume":"14","author":"Ullah","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111492_bib26","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib27","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1245\/s10434-007-9406-8","article-title":"Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a nationally funded peritonectomy center","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures","volume":"2","author":"Foster","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2026.111492_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/SLA.0000000000003532","article-title":"Specificity of procedure volume and its association with postoperative mortality in digestive cancer surgery: a nationwide study of 225,752 patients","volume":"270","author":"El","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111492_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/SLA.0000000000001768","article-title":"Is centralization needed for esophageal and gastric cancer patients with low operative risk?: a nationwide study","volume":"264","author":"Pasquer","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111492_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/SLA.0000000000002965","article-title":"Toward a consensus on centralization in surgery","volume":"268","author":"Vonlanthen","year":"2018","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2026.111492_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejso.2022.10.003","article-title":"Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers","volume":"49","author":"van Kooten","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.annpat.2024.05.003","article-title":"[RENAPE network: towards more equitable access to care and expertise for patients with rare peritoneal cancers]","volume":"44","author":"Villeneuve","year":"2024","journal-title":"Ann Pathol"},{"key":"10.1016\/j.ejso.2026.111492_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12876-022-02361-3","article-title":"Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly","volume":"22","author":"Pan","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejso.2026.111492_bib35","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ejso.2019.05.007","article-title":"Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: a multicenter study","volume":"45","author":"Sgarbura","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111492_bib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0399-8320(07)73964-7","article-title":"Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy","volume":"31","author":"Elias","year":"2007","journal-title":"Gastroenterol Clin Biol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326001113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326001113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:35:37Z","timestamp":1774697737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326001113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0748798326001113"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111492","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year of French multicentric experience in the management of peritoneal mesothelioma with 924 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111492"}}